By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Evidence-Based Guideline Summary: Evaluation, Diagnosis, and Management of Fascioscapulohumeral Muscular Dystrophy
Overview
Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: July 28, 2015
Contact: practice@apta.org
Content Type: CPG
Young Adult (19-24), Child (6-12), Adolescent (13-18), Adult (25-44)
Tawil R, Kissel JT, Heatwole C, et al; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine
You Might Also Like...
CPG
Evidence-Based Guideline Summary: Diagnosis and Treatment of Limb-Girdle and Distal DystrophiesOct 1, 2015
Offers potential solutions to challenging coverage scenarios that result from incomplete or conflicting evidence on limb-girdle and distal dystrophies
CPG
Evidence-Based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular DystrophyMar 31, 2015
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic
Clinical Summary
Muscular Dystrophy (MD): Duchenne and Becker (DBMD)Jan 19, 2014
PTs help people with DBMD improve their quality of life.